www.janssenschizophreniainjections.com Open in urlscan Pro
2606:4700::6812:15aa Public Scan

Back to summary

Submitted URL:
https://once-monthly-treatment.com.dev2-iu3gqsi-ldjjtjxsqcwee.us-4.platformsh.site/
Effective URL:
https://www.janssenschizophreniainjections.com/
Submission: On June 28 via api (June 28th 2021, 7:50:23 am UTC) from VN

Form analysis
1 forms found in the DOM

POST /

<form class="webform-client-form webform-client-form-6 survey-webform-wrapper-form webform-conditional-processed" enctype="multipart/form-data" id="webform-uuid-f299dd22-fdae-4608-aacc-a0aeeef5e921" action="/" method="post" accept-charset="UTF-8"
  novalidate="novalidate">
  <div>
    <div class="webform-progressbar" style="display: none;">
      <div class="webform-progressbar-outer">
        <div class="webform-progressbar-inner" style="width: 0%">&nbsp;</div>
        <span class="webform-progressbar-page current" style="left: 0%; display: none;">
          <span class="webform-progressbar-page-number">1</span>
        </span>
        <span class="webform-progressbar-page" style="left: 25%">
          <span class="webform-progressbar-page-number">2</span>
        </span>
        <span class="webform-progressbar-page" style="left: 50%">
          <span class="webform-progressbar-page-number">3</span>
        </span>
        <span class="webform-progressbar-page" style="left: 75%">
          <span class="webform-progressbar-page-number">4</span>
        </span>
        <span class="webform-progressbar-page" style="left: 100%">
          <span class="webform-progressbar-page-number">5</span>
        </span>
      </div>
    </div>
    <div class="form-item webform-component webform-component-markup webform-component--welcome-markup form-group form-item form-type-markup form-group">
      <div>
        <div class="panel-flexible panels-flexible-new clearfix">
          <div class="panel-flexible-inside panels-flexible-new-inside">
            <div class="panels-flexible-region panels-flexible-region-new-center panels-flexible-region-first panels-flexible-region-last">
              <div class="inside panels-flexible-region-inside panels-flexible-region-new-center-inside panels-flexible-region-inside-first panels-flexible-region-inside-last">
                <div class="panel-pane pane-block pane-nodeblock-50059fc2215046cbba9bbed1681c3859">
                  <div class="pane-content">
                    <article id="node-246" class="node node-callout clearfix">
                      <div class="field field-name-body field-type-text-with-summary field-label-hidden">
                        <div class="field-items">
                          <div class="field-item even">
                            <h3> We Want Your Feedback!<br></h3>
                            <p> Would you take a brief survey so we can improve your experience on our website? </p>
                          </div>
                        </div>
                      </div>
                    </article>
                  </div>
                </div>
              </div>
            </div>
          </div>
        </div>
      </div>
    </div>
    <div class="form-item webform-component webform-component-checkboxes webform-component--age-check form-group form-item form-item-submitted-age-check form-type-checkboxes form-group">
      <div id="edit-submitted-age-check" class="form-checkboxes">
        <div class="form-item form-item-submitted-age-check-1 form-type-checkbox checkbox"> <label class="control-label" for="edit-submitted-age-check-1"><input required="required" type="checkbox" id="edit-submitted-age-check-1"
              name="submitted[age_check][1]" value="1" class="form-checkbox require-one-edit-submitted-age-check">I confirm that I am 18 years of age or older.</label>
        </div>
      </div> <label class="control-label element-invisible" for="edit-submitted-age-check">I am 18 years or older <span class="form-required" title="This field is required.">*</span></label>
    </div>
    <div class="form-item webform-component webform-component-markup webform-component--close-button form-group form-item form-type-markup form-group">
      <div>
        <div class="panel-flexible panels-flexible-new clearfix">
          <div class="panel-flexible-inside panels-flexible-new-inside">
            <div class="panels-flexible-region panels-flexible-region-new-center panels-flexible-region-first panels-flexible-region-last">
              <div class="inside panels-flexible-region-inside panels-flexible-region-new-center-inside panels-flexible-region-inside-first panels-flexible-region-inside-last">
                <div class="panel-pane pane-block pane-nodeblock-0279346802ca4412b776f979cb3a599b">
                  <div class="pane-content">
                    <article id="node-251" class="node node-callout clearfix">
                      <div class="field field-name-body field-type-text-with-summary field-label-hidden">
                        <div class="field-items">
                          <div class="field-item even">
                            <p>
                              <button class="btn btn-secondary" data-dismiss="modal" type="button">Close</button>
                            </p>
                            <div>
                              <p> Please note: Responses here will not be monitored for immediate assistance. For help with our products or any other questions, please contact 1-800-JANSSEN <span class="nowrap">(1-800-526-7736)</span>. </p>
                            </div>
                          </div>
                        </div>
                      </div>
                    </article>
                  </div>
                </div>
              </div>
            </div>
          </div>
        </div>
      </div>
    </div>
    <div class="form-item webform-component webform-component-markup webform-component--disclaimer-link form-group form-item form-type-markup form-group">
      <div>
        <div class="panel-flexible panels-flexible-new clearfix">
          <div class="panel-flexible-inside panels-flexible-new-inside">
            <div class="panels-flexible-region panels-flexible-region-new-center panels-flexible-region-first panels-flexible-region-last">
              <div class="inside panels-flexible-region-inside panels-flexible-region-new-center-inside panels-flexible-region-inside-first panels-flexible-region-inside-last">
                <div class="panel-pane pane-block pane-nodeblock-85fb130d92404213bfe33421141d58eb">
                  <h2 class="pane-title"> Survey Disclaimer Message Link </h2>
                  <div class="pane-content">
                    <article id="node-271" class="node node-callout clearfix">
                      <div class="field field-name-body field-type-text-with-summary field-label-hidden">
                        <div class="field-items">
                          <div class="field-item even">
                            <p> Talk to your doctor if you have questions.<br>Click here for <a href="/important-safety-information" target="_blank">Important Safety Information</a> and Product Information for
                              <a href="http://www.janssenlabels.com/package-insert/product-monograph/prescribing-information/INVEGA+SUSTENNA-pi.pdf" target="_blank">Invega Sustenna<sup>®</sup></a> or
                              <a href="http://www.janssenlabels.com/package-insert/product-monograph/prescribing-information/INVEGA+TRINZA-pi.pdf" target="_blank">Invega Trinza<sup>®</sup></a>. </p>
                          </div>
                        </div>
                      </div>
                    </article>
                  </div>
                </div>
              </div>
            </div>
          </div>
        </div>
      </div>
    </div><input type="hidden" name="details[sid]">
    <input type="hidden" name="details[page_num]" value="1">
    <input type="hidden" name="details[page_count]" value="5">
    <input type="hidden" name="details[finished]" value="0">
    <input type="hidden" name="form_build_id" value="form-yLcudI0V8dOHHa8V5lZcOe0SXN-VDWQ1NpqkzWuw3mc">
    <input type="hidden" name="form_id" value="webform_client_form_6">
    <input type="hidden" name="webform_ajax_wrapper_id" value="webform-ajax-wrapper-6">
    <div class="honeypot-textfield">
      <div class="form-item form-item-honeypot form-type-textfield form-group"> <label class="control-label" for="edit-honeypot">Leave this field blank</label>
        <input autocomplete="off" class="form-control form-text" type="text" id="edit-honeypot" name="honeypot" value="" size="20" maxlength="128">
      </div>
    </div>
    <div class="form-actions"><button class="webform-next button-primary survey-start-btn btn btn-default form-submit ajax-processed" type="submit" id="edit-webform-ajax-next-6" name="op" value="Click Here to Take Our Survey!">Click Here to Take Our
        Survey!</button>
    </div>
  </div>
</form>

Text Content

Skip to main content
Google Tag Manager

* Important Safety Information
* Important Product Information

* INVEGA SUSTENNA®
* INVEGA TRINZA®
* For Patients with Schizoaffective Disorder
* For Healthcare Professionals

* INVEGA SUSTENNA®
* INVEGA TRINZA®

Toggle navigation
* Home
* About schizophrenia

* About schizophrenia
* Treating schizophrenia
in adults
* Treatment Team
* Caregivers
* Janssen Portfolio of LAIs

* Janssen Portfolio of LAIs
* INVEGA SUSTENNA®
* INVEGA TRINZA®
* Support

* Patient support
* Cost support
* Adults living with schizophrenia
* Treatment Change Discussion Guide
* FAQs
* Glossary

* INVEGA SUSTENNA® for
Healthcare Professionals
* INVEGA TRINZA® for
Healthcare Professionals
* For Patients with
Schizoaffective Disorder

1 2 3 4 5

WE WANT YOUR FEEDBACK!

Would you take a brief survey so we can improve your experience on our website?

I confirm that I am 18 years of age or older.
I am 18 years or older *

Please note: Responses here will not be monitored for immediate assistance. For
help with our products or any other questions, please contact 1-800-JANSSEN
(1-800-526-7736).

SURVEY DISCLAIMER MESSAGE LINK

Talk to your doctor if you have questions.
Click here for Important Safety Information and Product Information for Invega
Sustenna® or Invega Trinza®.

Leave this field blank
Click Here to Take Our Survey!
Close

THE JANSSEN PORTFOLIO OF LONG-ACTING INJECTIONS

Featuring INVEGA SUSTENNA® and
INVEGA TRINZA®. Same active ingredient, different
long-acting treatment options for adult patients with schizophrenia.

Jump to...
* Top of page
* What long-acting treatments can offer
* Working on your recovery plan
* Real advice from real patients

WHAT LONG-ACTING TREATMENTS CAN OFFER

You didn’t choose to live with schizophrenia, but you have a choice in how you
manage it. It’s important to talk with your healthcare professional and learn
about all the treatment options available to you, like a long-term approach to
treatment with either INVEGA SUSTENNA® (paliperidone palmitate) and INVEGA
TRINZA® (paliperidone palmitate) from the Janssen portfolio of long-acting
injections (LAIs).

Treatment with LAIs can help you feel confident that the medication you need is
in your system for a month* or 3 months** with a single dose. LAIs can also help
control schizophrenia symptoms in adults and help delay another episode.

In a pivotal long-term study, 90% of adult patients taking INVEGA SUSTENNA® did
not experience a significant return of schizophrenia symptoms vs 66% of those
not treated. In a separate pivotal long-term study, 93% of adult patients taking
INVEGA TRINZA® did not experience a significant return of schizophrenia symptoms
vs 77% of those not treated.

WHAT LONG-ACTING TREATMENTS CAN OFFER

The Janssen portfolio of LAIs has 2 treatment options with the same active
ingredient, both designed to be gradually released to help control schizophrenia
symptoms and delay time to another relapse in adults. INVEGA SUSTENNA® is given
every month after 2 starting doses, and INVEGA TRINZA® is given once every 3
months to patients after they have been adequately treated with INVEGA SUSTENNA®
for at least 4 months.

*After receiving 2 starting doses when treating with INVEGA SUSTENNA®.

**When treating with INVEGA TRINZA® after being adequately treated with INVEGA
SUSTENNA® for approximately 4 months.

*After receiving 2 starting doses when treating with INVEGA SUSTENNA®.

**When treating with INVEGA TRINZA® after being adequately treated with INVEGA
SUSTENNA® for approximately 4 months.

WORKING ON YOUR RECOVERY PLAN

When you’re not focused on controlling schizophrenia symptoms and another
episode, you can focus more on moving forward with your personal treatment
goals. The schizophrenia recovery journey isn’t an end point—it’s a process.
That process is unique to you, so it will look different from what other people
may be experiencing. Your treatment path on your way to your recovery plan can
start with:

Learning about schizophrenia
Making an informed decision about which medication is right for you
Working with your Treatment Team to help you make and achieve your goals
Working with your loved one to help them make and achieve their goals
Video Player is loading.
Play Video
Play
Mute

Current Time 0:00
/
Duration 0:10
Loaded: 100.00%

0:00
Stream Type LIVE
Seek to live, currently behind liveLIVE
Remaining Time -0:10
1x
Playback Rate

Chapters
* Chapters

Descriptions
* descriptions off, selected

Captions
* captions settings, opens captions settings dialog
* captions off, selected

Audio Track
* default, selected

Picture-in-PictureFullscreen

This is a modal window.

Beginning of dialog window. Escape will cancel and close the window.

TextColorWhiteBlackRedGreenBlueYellowMagentaCyanTransparencyOpaqueSemi-TransparentBackgroundColorBlackWhiteRedGreenBlueYellowMagentaCyanTransparencyOpaqueSemi-TransparentTransparentWindowColorBlackWhiteRedGreenBlueYellowMagentaCyanTransparencyTransparentSemi-TransparentOpaque
Font Size50%75%100%125%150%175%200%300%400%Text Edge
StyleNoneRaisedDepressedUniformDropshadowFont FamilyProportional
Sans-SerifMonospace Sans-SerifProportional SerifMonospace SerifCasualScriptSmall
Caps
Reset restore all settings to the default valuesDone
Close Modal Dialog

End of dialog window.

Close Modal Dialog

This is a modal window. This modal can be closed by pressing the Escape key or
activating the close button.

* Elizabeth is a volunteer with the SHARE Network, a volunteer program dedicated
to helping adults living with schizophrenia share their personal health stories.

REAL ADVICE FROM
REAL PATIENTS*

Learn about LAIs

POTENTIAL SIDE
EFFECTS

As with any medicine, INVEGA SUSTENNA® or INVEGA TRINZA® may cause side effects
in some people, so the risks are important to consider as you and your
healthcare professional make decisions about your treatment.

The most common side effects for INVEGA SUSTENNA® include: injection site
reactions, sleepiness or drowsiness, dizziness, feeling of inner restlessness or
needing to be constantly moving, and abnormal muscle movements, including tremor
(shaking), shuffling, uncontrolled involuntary movements, and abnormal movements
of your eyes.

The most common side effects of INVEGA TRINZA® include: injection site
reactions, weight gain, headache, upper respiratory tract infections, feeling
restlessness or difficulty sitting still, slow movements, tremors, stiffness and
shuffling walk.

Tell your Treatment Team if you have any side effect that bothers you or does
not go away.

INDICATIONS

INVEGA TRINZA® (3-month paliperidone palmitate) is a prescription medicine given
by injection every 3 months by a healthcare professional and used to treat
schizophrenia. INVEGA TRINZA® is used in people who have been treated with
INVEGA SUSTENNA® (1-month paliperidone palmitate) for at least 4 months.

INVEGA SUSTENNA® (In-VEY-guh Suss-TEN-uh) (paliperidone palmitate) is a
prescription medicine given by injection by a healthcare professional. INVEGA
SUSTENNA® is used to treat schizophrenia in adults.

IMPORTANT SAFETY INFORMATION

What is the most important information I should know about INVEGA TRINZA® and
INVEGA SUSTENNA®?

INVEGA TRINZA® and INVEGA SUSTENNA® can cause serious side effects, including an
increased risk of death in elderly people who are confused, have memory loss,
and have lost touch with reality (dementia-related psychosis). INVEGA TRINZA®
and INVEGA SUSTENNA® are not for treating dementia-related psychosis.

Do not receive INVEGA TRINZA® or INVEGA SUSTENNA® if you are allergic to
paliperidone, paliperidone palmitate, risperidone, or any of the ingredients in
INVEGA TRINZA® or INVEGA SUSTENNA®. See the end of the Patient Information
leaflet in the full Prescribing Information for a complete list of INVEGA
TRINZA® and INVEGA SUSTENNA® ingredients.

Before you receive INVEGA TRINZA® or INVEGA SUSTENNA®, tell your healthcare
professional about all your medical conditions, including if you:

* have had Neuroleptic Malignant Syndrome (NMS)
* have or have had heart problems, including a heart attack, heart failure,
abnormal heart rhythm, or long QT syndrome
* have or have had low levels of potassium or magnesium in your blood
* have or have had uncontrolled movements of your tongue, face, mouth, or jaw
(tardive dyskinesia)
* have or have had kidney or liver problems
* have diabetes or have a family history of diabetes
* have had a low white blood cell count
* have had problems with dizziness or fainting or are being treated for high
blood pressure
* have or have had seizures or epilepsy
* have any other medical conditions
* are pregnant or plan to become pregnant. It is not known if INVEGA TRINZA® or
INVEGA SUSTENNA® will harm your unborn baby
* If you become pregnant while taking INVEGA TRINZA® or INVEGA SUSTENNA®,
talk to your healthcare professional about registering with the National
Pregnancy Registry for Atypical Antipsychotics. You can register by calling
1-866-961-2388 or
visit http://womensmentalhealth.org/clinical-and-research-programs/pregnancyregistry.
* Infants born to women who are treated with INVEGA TRINZA® or INVEGA
SUSTENNA® may experience symptoms such as tremors, irritability, excessive
sleepiness, eye twitching, muscle spasms, decreased appetite, difficulty
breathing, or abnormal movement of arms and legs. Let your healthcare
professional know if these symptoms occur.
* are breastfeeding or plan to breastfeed. INVEGA TRINZA® or INVEGA SUSTENNA®
can pass into your breast milk. Talk to your healthcare professional about
the best way to feed your baby if you receive INVEGA TRINZA® or INVEGA
SUSTENNA®.

Tell your healthcare professional about all the medicines you take, including
prescription and over-the-counter medicines, vitamins, and herbal supplements.
Know the medicines you take. Keep a list of them to show to your healthcare
professional or pharmacist when you get a new medicine.

Patients (particularly the elderly) taking antipsychotics with certain health
conditions or those on long-term therapy should be evaluated by their healthcare
professional for the potential risk of falls.

What should I avoid while receiving INVEGA TRINZA® or INVEGA SUSTENNA®?

* INVEGA TRINZA® and INVEGA SUSTENNA® may affect your ability to make
decisions, think clearly, or react quickly. Do not drive, operate heavy
machinery, or do other dangerous activities until you know how INVEGA
TRINZA® or INVEGA SUSTENNA® affects you.
* Avoid getting overheated or dehydrated.

INVEGA TRINZA® and INVEGA SUSTENNA® may cause serious side effects, including:

* See “What is the most important information I should know about INVEGA
TRINZA® and INVEGA SUSTENNA®?”
* stroke in elderly people (cerebrovascular problems) that can lead to death
* Neuroleptic Malignant Syndrome (NMS). NMS is a rare but very serious problem
that can happen in people who receive INVEGA TRINZA® or INVEGA SUSTENNA®. NMS
can cause death and must be treated in a hospital. Call your healthcare
professional right away if you become severely ill and have any of these
symptoms: high fever; severe muscle stiffness; confusion; loss of
consciousness; changes in your breathing, heartbeat, and blood pressure.
* problems with your heartbeat. These heart problems can cause death. Call your
healthcare professional right away if you have any of these symptoms: passing
out or feeling like you will pass out, dizziness, or feeling as if your heart
is pounding or missing beats.
* uncontrolled movements of your tongue, face, mouth, or jaw (tardive
dyskinesia)
* metabolic changes. Metabolic changes may include high blood sugar
(hyperglycemia), diabetes mellitus and changes in the fat levels in your
blood (dyslipidemia), and weight gain.
* low blood pressure and fainting
* changes in your blood cell counts
* high level of prolactin in your blood (hyperprolactinemia). INVEGA
TRINZA® or INVEGA SUSTENNA® may cause a rise in the blood levels of a hormone
called prolactin (hyperprolactinemia) that may cause side effects including
missed menstrual periods, leakage of milk from the breasts, development of
breasts in men, or problems with erection.
* problems thinking clearly and moving your body
* seizures
* difficulty swallowing that can cause food or liquid to get into your lungs
* prolonged or painful erection lasting more than 4 hours. Call your healthcare
professional or go to your nearest emergency room right away if you have an
erection that lasts more than 4 hours.
* problems with control of your body temperature, especially when you exercise
a lot or spend time doing things that make you warm. It is important for you
to drink water to avoid dehydration.

The most common side effects of INVEGA SUSTENNA® include: injection site
reactions; sleepiness or drowsiness; dizziness; feeling of inner restlessness or
needing to be constantly moving; abnormal muscle movements, including tremor
(shaking), shuffling, uncontrolled involuntary movements, and abnormal movements
of your eyes.

Tell your healthcare professional if you have any side effect that bothers you
or does not go away. These are not all the possible side effects of INVEGA
TRINZA® or INVEGA SUSTENNA®. For more information, ask your healthcare
professional or pharmacist.

Call your healthcare professional for medical advice about side effects. You may
report side effects of prescription drugs to the FDA at 1‑800‑FDA‑1088.

General information about the safe and effective use of INVEGA TRINZA® or INVEGA
SUSTENNA®

Medicines are sometimes prescribed for purposes other than those listed in a
Patient Information leaflet. Do not use INVEGA TRINZA® or INVEGA SUSTENNA® for a
condition for which it was not prescribed. Do not give INVEGA TRINZA® or INVEGA
SUSTENNA® to other people, even if they have the same symptoms that you have. It
may harm them. You can ask your pharmacist or healthcare professional for
information about INVEGA TRINZA® or INVEGA SUSTENNA® that is written for
healthcare professionals.

This Patient Information leaflet summarizes the most important information about
INVEGA TRINZA® and INVEGA SUSTENNA®. If you would like more information, talk
with your healthcare professional.

You can ask your healthcare professional or pharmacist for more information that
is written for healthcare professionals. For more information, go to
www.invegatrinza.com or www.invegasustenna.com or call 1‑800‑526‑7736.

Please click to read the full Prescribing Information, including Boxed WARNING,
for INVEGA TRINZA® and INVEGA SUSTENNA® and discuss any questions you have with
your healthcare professional.

cp-64207v2

The information contained in this section of the site is intended for US
healthcare professionals only. Click the appropriate link below:

I am a healthcare professional
Close
×

The information contained in this section of the site is intended for US
healthcare professionals only. Click the appropriate link below:

I am a healthcare professional
Close

* Legal notice
* Privacy policy
* Contact us
* Site map

This site is published by Janssen Pharmaceuticals, Inc., which is solely
responsible for its contents. The material on this site is intended only as
informational or as an educational aid and it is not intended to be taken as
medical advice. The ultimate responsibility for patient care resides with a
healthcare professional.

This information is intended for the use of patients and caregivers in the
United States and Puerto Rico only. Laws, regulatory requirements, and medical
practices for pharmaceutical products vary from country to country. The
Prescribing Information included here may not be appropriate for use outside the
United States and Puerto Rico.

Third party trademarks used herein are trademarks of their respective owners.

Legal Notice | Privacy Policy | Contact UsSite Map

Do not sell my personal information

Last updated March 2021

Last Updated March 2021

Thank you for visiting www.janssenschizophreniainjections.com.

By clicking “continue” below, you will be taken to [extlink:external-url], a Web
site that may contain links or references to other Web sites to which our
Privacy Policy may not apply. We encourage you to read the Privacy Policy of
every Web site you visit. Our Privacy Policy is located at privacy-policy.

You are solely responsible for your interactions with such Web sites.

Cancel

Continue